Host-based Th2 cell therapy for prolongation of cardiac allograft viability

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Amarnath, Shoba ^a   Chen, Hao ^b,c   Foley, Jason E ^a   Costanzo, Carliann M ^a   Sennesh, Joel D ^d   Solomon, Michael A ^b,e   Fowler, Daniel H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c FUDAN UNIVERSITY   (China)

^d INOVA FAIRFAX HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; RAPAMYCIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HOST CELL; IMMUNOTHERAPY; LYMPHOID ORGAN; MALE; NONHUMAN; RAT; T LYMPHOCYTE ACTIVATION; TH2 CELL; ALLOTRANSPLANTATION; ANIMAL; BIOLOGICAL THERAPY; CD4+ T LYMPHOCYTE; CYTOLOGY; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHENOTYPE; TREATMENT OUTCOME;

RATTUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; CYTOKINES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHENOTYPE; RATS; SIROLIMUS; TH2 CELLS; TISSUE THERAPY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79955741366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018885     Document Type: Article

References (46)

1. Cooley D FO, Panvini G, (1983) Cardiac and cardiopulmonary transplantation using cyclosporine for immunosuppresion:recent texas Heart Institute experience. Transplant Proc 15.
2. Patel JK, Kobashigawa JA, (2004) Cardiac transplant experience with cyclosporine. Transplant Proc 36: 323S-330S.
3. Maes BD, Vanrenterghem YF, (2004) Cyclosporine: advantages versus disadvantages vis-a-vis tacrolimus. Transplant Proc 36: 40S-49S.
4. Khush KK, Valantine HA, (2009) New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs 14: 1-21.
5. Egidi MF, Gaber AO, (2003) Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 75: 572; author reply 573.
6. Woodruff MF, van Rood JJ, (1983) Possible implications of the effect of blood transfusion on allograft survival. Lancet 1: 1201-1203.
7. Kitade H, Kawai M, Koshiba T, Giulietti A, Overbergh L, et al. (2004) Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation 78: 1747-1755.
8. Levy AE, Alexander JW, Babcock GF, (1997) A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts. Transpl Immunol 5: 83-88.
9. Kataoka M, Shimizu Y, Margenthaler JA, Landeros K, Otomo N, et al. (2002) Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion. Surgery 132: 167-172.
10. Kataoka M, Margenthaler JA, Ku G, Eilers M, Flye MW, (2003) "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants. Surgery 134: 227-234.
11. Abe Y, Urakami H, Ostanin D, Zibari G, Hayashida T, et al. (2009) Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts. PLoS One 4: e7840.
12. Mariotti J, Foley J, Ryan K, Buxhoeveden N, Kapoor V, et al. (2008) Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway. Blood 112: 4765-4775.
13. Mariotti J, Foley J, Jung U, Borenstein T, Kantardzic N, et al. (2008) Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection. J Immunol 180: 89-105.
14. Isobe M, Suzuki J, Yamazaki S, Yazaki Y, Horie S, et al. (1997) Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation 96: 2247-2253.
15. Foley JE, Jung U, Miera A, Borenstein T, Mariotti J, et al. (2005) Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. J Immunol 175: 5732-5743.
16. Jung U, Foley JE, Erdmann AA, Eckhaus MA, Fowler DH, (2003) CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects. Blood 102: 3439-3446.
17. Jung U, Foley JE, Erdmann AA, Toda Y, Borenstein T, et al. (2006) Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. Biol Blood Marrow Transplant 12: 905-918.
18. Opelz G, Terasaki PI, Graver B, Sasaki N, Langston M, et al. (1979) Correlation between number of pretransplant blood transfusions and kidney graft survival. Transplant Proc 11: 145-147.
19. Cochrum K, Hanes D, Potter D, Perkins H, Amend W, et al. (1981) Improved graft survival following donor-specific blood transfusions. Transplant Proc 13: 1657-1661.
20. Paulos CM, Suhoski MM, Plesa G, Jiang T, Basu S, et al. (2008) Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunol Res 42: 182-196.
21. Shapira OM, Mor E, Reshef T, Pfeffermann RA, Cohen IR, (1993) Prolongation of survival of rat cardiac allografts by T cell vaccination. J Clin Invest 91: 388-390.
22. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, et al. (2007) In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109: 827-835.
23. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, et al. (2008) Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14: 88-92.
24. Cobbold SP, Adams E, Graca L, Daley S, Yates S, et al. (2006) Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev 213: 239-255.
25. Kang SM, Tang Q, Bluestone JA, (2007) CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant 7: 1457-1463.
26. Young KJ, Yang L, Phillips MJ, Zhang L, (2002) Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100: 3408-3414.
27. Zhai Y, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW, (1999) Th1 and Th2 cytokines in organ transplantation: paradigm lost? Crit Rev Immunol 19: 155-172.
28. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, et al. (1997) Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 158: 1572-1581.
29. Ke B, Ritter T, Kato H, Zhai Y, Li J, et al. (2000) Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 164: 5739-5745.
30. Battaglia M, Stabilini A, Roncarolo MG, (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
31. Amarnath S, Flomerfelt FA, Costanzo CM, Foley JE, Mariotti J, et al. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy 6.
32. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE, (1994) Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J Immunol 152: 1004-1013.
33. Yamada A, Laufer TM, Gerth AJ, Chase CM, Colvin RB, et al. (2003) Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transplant 3: 23-27.
34. Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL, (2008) Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant 8: 1652-1661.
35. Hall BM, Plain KM, Verma ND, Tran GT, Boyd R, et al. (2007) Transfer of allograft specific tolerance requires CD4+CD25+T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens. Transplantation 83: 1075-1084.
36. Delfs MW, Furukawa Y, Mitchell RN, Lichtman AH, (2001) CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 71: 606-610.
37. Illigens BM, Yamada A, Anosova N, Dong VM, Sayegh MH, et al. (2009) Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol 39: 3000-3009.
38. Lucas JG, Co JP, Nwaogwugwu UT, Dosani I, Sureshkumar KK, (2011) Antibody-mediated rejection in kidney transplantation: an update. Expert Opin Pharmacother 12 (4): 579-592.
39. Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, et al. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
40. Li Y, Zheng XX, Li XC, Zand MS, Strom TB, (1998) Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 66: 1387-1388.
41. Gao W, Lu Y, El Essawy B, Oukka M, Kuchroo VK, et al. (2007) Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 7: 1722-1732.
42. Raimondi G, Sumpter TL, Matta BM, Pillai M, Corbitt N, et al. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol 184: 624-636.
43. Levine BL, Bernstein WB, Connors M, Craighead N, Lindsten T, et al. (1997) Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol 159: 5921-5930.
44. Yokoyama H, Ohmi M, Murata S, Nakame T, Tabayashi K, et al. (1995) Proposal of a working left heart model with a heterotopic transplantation technique in rats. J Heart Lung Transplant 14: 706-712.
45. Deans KJ, Minneci PC, Chen H, Kern SJ, Logun C, et al. (2009) Impact of animal strain on gene expression in a rat model of acute cardiac rejection. BMC Genomics 10: 280.
46. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, et al. (2005) Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24: 1710-1720.